SlideShare ist ein Scribd-Unternehmen logo
1 von 32
Vasculitis Syndrome
           An Approach
                And
   Basic Principles of Treatment


   Dr. Sachin Verma MD, FICM, FCCS, ICFC
      Fellowship in Intensive Care Medicine
         Infection Control Fellows Course
 Consultant Internal Medicine and Critical Care
           Ivy Hospital Sector 71 Mohali
Web:- http://www.medicinedoctorinchandigarh.com
              Mob:- +91-7508677495
Introduction
• Vasculitides are a hetrogenous group of
  conditions characterized by inflammation
  and necrosis of blood vessels.

• A broad group of syndromes may result
  from this process,since any type,size, and
  location of vessel may be involved.
Classification of vasculitides:
 Various attempts made to create a classification of
  vasculitides.

 But it remains a matter of controversy.

 Most classifications are based on:
  1. Size vessels it involves.
  2. Histological findings from involved vessels.
   3.Combination of both vessel size and histological
  findings.
   But all scheme of classification is imperfect.
Pathophysiology and pathogenesis
 Pathogenic immune-complex formation:
 1.Most widely accepted mechanism
 2.Casual role is not clearly established
     Examples- PAN, EMC
 Antineutrophilic cytoplasmic antibodies(ANCA):
    Two types- 1. c-ANCA, Examples; WG
               2. p-ANCA,Examples;MPA, CSS, Crecentric
  GN, GPS , WG
 Pathogenic T-Lymphocytes response and granuloma
  formation:
  Examples; WG , Giant cell arteritis,Takayasu arteritis
           CSS
Etiopathogenic classification incorporating the
     modified CHCC Classification by Lie
DOMINENT                  PRIMARY VASCULITIS         PATHOGENESIS
VESSELS


LARGE ARTERIES            Temporal arteritis         T cell mediated
                          Takayasu’s arteritis


MEDIUM ARTERIES           Classical PAN              Immune complex related

                          Kawasaki’s disease         Antibody mediated
                                                     hypersensitivity
SMALL AND MEDIUM          Wegener’s granulomatosis
SIZE ARTERIES             CSS                        Antibody mediated
                          MSA                        (ANCA)

SMALL VESSEL VASCULITIS   HSP
(Leukocytoclastic)        EMC                        Immune complex mediated
                          CUTANEOUS LCV
The most recent classification scheme proposed
    by the American College of Rheumatology (ACR)
• Uses both vessel size and type of inflammatory infiltrate.
• It classifies vasculitis as follows:
  Polyarteritis nodosa (PAN),
  Churg-Strauss syndrome,
  Wegener's granulomatosis,
  Hypersensitivity vasculitis,
  Henoch-Schönlein purpura,
  Giant cell arteritis,
  Takayasu's arteritis,
  Granulomatous angitis of CNS,                    Berger's
  disease, and
  Kawasaki disease
INDIAN PERSPECTIVE
•   Reliable epidemiological data from india is
    not available
•   Takayasu’s arteritis is commonest
    vasculitis described.
•   Temporal arteritis is extremly uncommon
•   Patients with WG are seen in significant
    number in north,but rare in south.
•   Classical PAN has been described all over.
Frequency distribution of vasculitic disorders in
                  India (N=1064)*
      DISEASE                     NO.       PERCENTAGE
Aortoarteritis               215           20.20
Giant cell arteritis         35             3.36
Polyarteritis nodosa (PAN)   95            8.83
Cutaneous PAN                13            1.22
Wegener’s granulomatosis     147           13.83
Microscopic polyangiitis     42            3.94
Churg Straus syndrome        19            1.78
Henoch Schonlein purpura     232           21.80
Small vessel vasculitis      61            5.73
Behcet’s disease             145           13.62
Kawasaki disease             05            0.46
Undiagnosed                  50            4.69
Others**                     6             0.56
CLINICAL MANIFESTATIONS
• The Vasculitides are truly a ‘multisystem’
  diseases. No organ or system is spared.

• General Symptomatology :
   Fever
   Weight loss
   Malaise
   Fatigue
   Night sweats
   Anemia
   Generalised aches and pain
CLINICAL MANIFESTATIONS : A GUIDE TO THE TYPE OF VESSELS INVOLVED
                    CLINICAL MANIFESTATIONS:
LARGE VESSELS               MEDIUM VESSELS               SMALL VESSELS

Limb claudication           Red and blue Panniculitis    Purpura



Asymmetric blood pressure   Ulcer                        Vesicobullous lesions


Absence of pulses           Livedo reticularis.          Urticaria

Bruits                      Digital gangrene             Glomerulonephritis

Aortic dilatation           Mononeuritis multiplex       Alveolar haemorrhage

Renovascular Hypertension   Microaneurysm                Splinter haemorrhage


                            Reno-vascular hypertension   Uveitis,episcleritis,scleritis


                                                         Mucosal ulcer in bowel
Continue…
• SKIN:   Skin commonly involved.
o Palpable purpura is commonest dermal
  lesion.
o Other specific lesions are:
 nodules and plaques which may ulcerate
 Infarcts
 Ulcers
 Pyoderma gangrenosum
 Wide spread skin necrosis and gangrene.
 Macules, papules,vesicles, blisters, and small
  bullae has been described.
SKIN LESIONS
Muscles and Joints:
 Features are common, but nonspecific.
      Arthralgia and Arthritis
      Generalised Myalgia and Weakness
      Claudication, Pain
Eye ,Ear ,Nose and Throat:
  Scleritis
  Scleromalacia
  Perforation of globe
  Uveatis
  Recurrent Otitis media
  Hearing loss
  Recurrent sinusitis, nasal septum damage
  Several and recurrent oral ulcerations
Airways and Lungs:
  Stridor
  Ventilatory compromise
  Cough
  Chest pain
  Expectoration and Hemoptysis
  Pulmonary lesions like:
                  infiltrate
                  nodules
                  cavities
                  mass lesions
                  abscess
Gastrointestinal tract:
 most important G.I. manifestations are due to
 bowel ischemia.


Kidneys:
 Great diversity of lesions:
     Renovascular hypertension
     Infarction and Hematoma of kidneys
     Mild GNs to rapidly progressive GNs
Nervous system:
  Peripheral Neuropathy, Stroke

Reproductive system:
    Testicular Infarction
    Scrotal ulcers
    Penile ulcers on Glans and Shaft

Cardiovascular system :
    Pericarditis, Myocardial infarction
    Aneurysmal rupture
Approach to the patient
• Diagnosis of vasculitis is considered in an any
  patient with unexplained illness.
• Certain clinical abnormalities when present
  alone or in combination suggest a diagnosis of
  vasculitis like…
  1.Palpable purpura 2.Pulmanary infiltrates
  3. Microscopic hematuria
  4.Chronic inflammatory sinusitis
  5.Unexplained ischemic events
  6.Glomerulonephritis
          with evidence of multisystem disease
Laboratory Work-up
• First to exclude the diseases which can
  mimic vasculitis.
• To establish the category of vasculitis
  syndrome.
 Hemogram :
  Normocytic Normochromic anemia
  Leukocytosis(>10% Eosinophils in CSS)
Acute phase reactants:
  Raised ESR, CRP, alpha-2 globulin,
  fibrinogen, Thrombocytosis, ALP
Continue….
Urine analysis:
       Hematuria
       Proteinuria
Serum proteins:
 Hypergammaglobulinemia
 (mostly IgG type, IgA in HSP, WG)
 Complements levels usually decreased
Antineutrophil cytoplasmic
  autoantibodies (ANCA):
  c-ANCA p-ANCA A or x-ANCA
Continue….
Organ biopsy:
 Gold standard for diagnosis of vasculitis.

Angiography :
 Especially for medium and large vessels.
 Others:
  X-rays, CT Scan, MRI of thorax
  MRA
  USG Studies
Basic principals of treatment
• Glucocorticoids

• Glucocorticoids + cytototoxic drugs

• Antiviral therapy if indicated

• Plasma exchange and IV Ig + or aspirin

• Surgical correction and Angioplasty
Continue…
• Sympotomatic mangement in cases of
  hypersensitivity vasculitis

• White blood cell counts every 1-2wks and
  WBC count should be maintained above >
  3000/microL.

• TMP-SMX should be given to every patient
  receiving glucocorticoids and cytotoxic
  drugs combination therapy.
SMALL AND MEDIUM
        SIZED
VASCULITIS SYNDROMES
WEGENNER’S       CHURG SRAUSS    MICROSCOPIC
                  GRANULOMATOS     SYNDROME        POLYANGITIS
                  IS                                               PAN

                                   1.2:1           OVER ALL        OVER ALL
                  1:1              NO MUCH DIFF.   UNKNOWN         UNKNOWN
 M:F                               FROM WESTRN
                  1:14(INDIA)      DATA                            4.5:1(INDIA)

TYPE OF VESSELS   SMALL ARTERIES   SMALL AND       SMALL VESSELS   SMALL AND
INVOLVED          AND VEINS        MEDIUM SIZED    (ARTERIES,      MEDIUM SIZED
                                   VESSELS         CAPILLARIES,    ARTERIES ONLY
                                                   VENULES)

SPECIFIC          TRIAD: UPPER     EXTRA           PULMONARY       PULMONARY
FEATURE           AND LOWER AIR    VASCULAR        CAPILLARIES     ARTERY NOT
                  WAYS WITH        GRANULOMA       INVOLVED,       INVOLVED,
                  KIDNEY LESIONS                   GNs +NT         ANEURYSMS

LABORATORY        C-ANCA(>90%)     p-ANCA (>48%)   p-ANCA (75%)    HEP B
FINDINGS          FALSE +VE                                        ANTIGENEMIA,
                  REPORTED                                         HAIRY CELL
                                                                   LEUKEMIA
LARGE SIZED VESSELS
VASCULITIS SYNDROME
 TAKAYASU’S ATERITIS                 GIANT CEL ATERITIS
 (NON-SPECIFIC AORTO-ARTERITIS)         (TEMPORAL ARTERITIS)


 SPECIFIC FEMALE SEX                MORE COMMON IN FEMALE
PREDILICTIONS
                                     MORE COMMON IN WESTERN
MORE COMMON IN ASIA                 COUNTRIES
       M:F- 1:1.6 (INDIA)            RARE IN INDIA
             1:9 (JAPAN)
AGE: 15-25 YEARS
                                     AGE: MORE THAN 50 YEARS
C/F: GENERAL SYMPTOMS WITH
VASCULAR SYMPTOMS
 HYPERTENSION IS MOST COMMON        ASSOCIATED WITH POLYMYALGIA
PRESENTATION.                        RHEUMATICA.

DISEAESE CLASSIFY ON THE BASIS OF
SITE OF INVOLVEMENT OF AORTA AND     DISEASE INVOLVES
ITS BRNCHES.                         CHARECTERISTICALLY ONE OR MORE
                                     BRANCHES OF CAROTID ARTERY.
MIXED INVOLVEMENT IS THE
CLASSIFICATION OF TAKAYASU’S ARTERITIS
SUMMARY
• PATIENT SUSPECTED FOR PRIMARY VASCULITIS.

• RULE OUT THE CAUSES WHICH CAN MIMIC VASCULITIS.

• LOOK FOR DEMOGRAPHIC CHARACTERISTICS LIKE AGE,SEX,
  ETHINICITY,SMOKING STATUS.

• DETERMINE THE SIZE OF VESSELS INVOLVED AND CATEGORIES THE
  TYPE OF VASCULITIS.

• EXTENT OF ORGAN DAMGE TO BE ASSESSED.

• SPECIFIC LABORATORIES WORK UP REQUIRED FOR CONFIRMATION OF
  DIAGNOSIS.

• DECIDE THE APPOPRIATE TREATMENT
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis syndromes
Vasculitis syndromesVasculitis syndromes
Vasculitis syndromes
 
Dermatomyositis Dr. Saad Raheem Abed
Dermatomyositis Dr. Saad Raheem AbedDermatomyositis Dr. Saad Raheem Abed
Dermatomyositis Dr. Saad Raheem Abed
 
Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.
 
Systematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail ValivachSystematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail Valivach
 
Granulomatosis with polyangiitis
Granulomatosis with polyangiitisGranulomatosis with polyangiitis
Granulomatosis with polyangiitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
THROMBOTIC MICROANGIOPATHY
THROMBOTIC MICROANGIOPATHY THROMBOTIC MICROANGIOPATHY
THROMBOTIC MICROANGIOPATHY
 
Pediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullahPediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullah
 
Cutaneous vasculitis
Cutaneous vasculitisCutaneous vasculitis
Cutaneous vasculitis
 
Cutaneous Vasculitis
Cutaneous VasculitisCutaneous Vasculitis
Cutaneous Vasculitis
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Sle
SleSle
Sle
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
 
Update on vasculitis
Update on vasculitisUpdate on vasculitis
Update on vasculitis
 
Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016
 

Ähnlich wie Vasculitis syndrome an approach -and-basic principles of treatment

Ähnlich wie Vasculitis syndrome an approach -and-basic principles of treatment (20)

Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)
 
Vasculitis 2015 undergraduate
Vasculitis 2015 undergraduateVasculitis 2015 undergraduate
Vasculitis 2015 undergraduate
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBM
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptx
 
VASCULITIS AND UPDATES
VASCULITIS  AND UPDATESVASCULITIS  AND UPDATES
VASCULITIS AND UPDATES
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
Primary cns vasculitis
Primary cns vasculitisPrimary cns vasculitis
Primary cns vasculitis
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
 
Vasculitis for undergraduates
Vasculitis   for undergraduatesVasculitis   for undergraduates
Vasculitis for undergraduates
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Cns vasculitis
Cns vasculitisCns vasculitis
Cns vasculitis
 
9a1c wg mitchell-7-5-06
9a1c wg mitchell-7-5-069a1c wg mitchell-7-5-06
9a1c wg mitchell-7-5-06
 
9a1c wg mitchell-7-5-06
9a1c wg mitchell-7-5-069a1c wg mitchell-7-5-06
9a1c wg mitchell-7-5-06
 
Vasculitis and varicose veins
Vasculitis and varicose veinsVasculitis and varicose veins
Vasculitis and varicose veins
 
Vasculitis.pptx
Vasculitis.pptxVasculitis.pptx
Vasculitis.pptx
 
vasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptxvasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptx
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
 
APPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptxAPPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptx
 

Mehr von Sachin Verma

Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertensionSachin Verma
 
Focus on triglycerides
Focus on triglyceridesFocus on triglycerides
Focus on triglyceridesSachin Verma
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteinsSachin Verma
 
Type 2 dm gdm new updates & guidelines
Type 2 dm  gdm new updates & guidelinesType 2 dm  gdm new updates & guidelines
Type 2 dm gdm new updates & guidelinesSachin Verma
 
Tuberculosis update
Tuberculosis updateTuberculosis update
Tuberculosis updateSachin Verma
 
Prevention of nosocomial infections
Prevention of nosocomial infectionsPrevention of nosocomial infections
Prevention of nosocomial infectionsSachin Verma
 
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategy
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategyVertigo –the dizzy patient an evidence-based diagnosis and treatment strategy
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategySachin Verma
 
Urine examination how to approach final.ppt1
Urine examination  how to approach final.ppt1Urine examination  how to approach final.ppt1
Urine examination how to approach final.ppt1Sachin Verma
 
Proteinuria how to approach final
Proteinuria   how to approach finalProteinuria   how to approach final
Proteinuria how to approach finalSachin Verma
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndromeSachin Verma
 
Hypertension management
Hypertension managementHypertension management
Hypertension managementSachin Verma
 
Electrolyte imbalance potassium
Electrolyte imbalance    potassiumElectrolyte imbalance    potassium
Electrolyte imbalance potassiumSachin Verma
 
Approach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakarApproach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakarSachin Verma
 
Approach to a patient of anemia1 copy
Approach to a patient of anemia1   copyApproach to a patient of anemia1   copy
Approach to a patient of anemia1 copySachin Verma
 

Mehr von Sachin Verma (20)

Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
Focus on triglycerides
Focus on triglyceridesFocus on triglycerides
Focus on triglycerides
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteins
 
Type 2 dm gdm new updates & guidelines
Type 2 dm  gdm new updates & guidelinesType 2 dm  gdm new updates & guidelines
Type 2 dm gdm new updates & guidelines
 
Tuberculosis update
Tuberculosis updateTuberculosis update
Tuberculosis update
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
Prevention of nosocomial infections
Prevention of nosocomial infectionsPrevention of nosocomial infections
Prevention of nosocomial infections
 
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategy
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategyVertigo –the dizzy patient an evidence-based diagnosis and treatment strategy
Vertigo –the dizzy patient an evidence-based diagnosis and treatment strategy
 
Urine examination how to approach final.ppt1
Urine examination  how to approach final.ppt1Urine examination  how to approach final.ppt1
Urine examination how to approach final.ppt1
 
Thyroid final
Thyroid finalThyroid final
Thyroid final
 
Snake bite
Snake biteSnake bite
Snake bite
 
Proteinuria how to approach final
Proteinuria   how to approach finalProteinuria   how to approach final
Proteinuria how to approach final
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Sodium metabolism
Sodium metabolismSodium metabolism
Sodium metabolism
 
Management of arf
Management of arfManagement of arf
Management of arf
 
Hypertension management
Hypertension managementHypertension management
Hypertension management
 
Electrolyte imbalance potassium
Electrolyte imbalance    potassiumElectrolyte imbalance    potassium
Electrolyte imbalance potassium
 
Dengue
DengueDengue
Dengue
 
Approach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakarApproach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakar
 
Approach to a patient of anemia1 copy
Approach to a patient of anemia1   copyApproach to a patient of anemia1   copy
Approach to a patient of anemia1 copy
 

Kürzlich hochgeladen

low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 

Kürzlich hochgeladen (20)

low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 

Vasculitis syndrome an approach -and-basic principles of treatment

  • 1. Vasculitis Syndrome An Approach And Basic Principles of Treatment Dr. Sachin Verma MD, FICM, FCCS, ICFC Fellowship in Intensive Care Medicine Infection Control Fellows Course Consultant Internal Medicine and Critical Care Ivy Hospital Sector 71 Mohali Web:- http://www.medicinedoctorinchandigarh.com Mob:- +91-7508677495
  • 2. Introduction • Vasculitides are a hetrogenous group of conditions characterized by inflammation and necrosis of blood vessels. • A broad group of syndromes may result from this process,since any type,size, and location of vessel may be involved.
  • 3. Classification of vasculitides:  Various attempts made to create a classification of vasculitides.  But it remains a matter of controversy.  Most classifications are based on: 1. Size vessels it involves. 2. Histological findings from involved vessels. 3.Combination of both vessel size and histological findings. But all scheme of classification is imperfect.
  • 4. Pathophysiology and pathogenesis  Pathogenic immune-complex formation:  1.Most widely accepted mechanism  2.Casual role is not clearly established Examples- PAN, EMC  Antineutrophilic cytoplasmic antibodies(ANCA):  Two types- 1. c-ANCA, Examples; WG 2. p-ANCA,Examples;MPA, CSS, Crecentric GN, GPS , WG  Pathogenic T-Lymphocytes response and granuloma formation: Examples; WG , Giant cell arteritis,Takayasu arteritis CSS
  • 5. Etiopathogenic classification incorporating the modified CHCC Classification by Lie DOMINENT PRIMARY VASCULITIS PATHOGENESIS VESSELS LARGE ARTERIES Temporal arteritis T cell mediated Takayasu’s arteritis MEDIUM ARTERIES Classical PAN Immune complex related Kawasaki’s disease Antibody mediated hypersensitivity SMALL AND MEDIUM Wegener’s granulomatosis SIZE ARTERIES CSS Antibody mediated MSA (ANCA) SMALL VESSEL VASCULITIS HSP (Leukocytoclastic) EMC Immune complex mediated CUTANEOUS LCV
  • 6. The most recent classification scheme proposed by the American College of Rheumatology (ACR) • Uses both vessel size and type of inflammatory infiltrate. • It classifies vasculitis as follows: Polyarteritis nodosa (PAN), Churg-Strauss syndrome, Wegener's granulomatosis, Hypersensitivity vasculitis, Henoch-Schönlein purpura, Giant cell arteritis, Takayasu's arteritis, Granulomatous angitis of CNS, Berger's disease, and Kawasaki disease
  • 7. INDIAN PERSPECTIVE • Reliable epidemiological data from india is not available • Takayasu’s arteritis is commonest vasculitis described. • Temporal arteritis is extremly uncommon • Patients with WG are seen in significant number in north,but rare in south. • Classical PAN has been described all over.
  • 8. Frequency distribution of vasculitic disorders in India (N=1064)* DISEASE NO. PERCENTAGE Aortoarteritis 215 20.20 Giant cell arteritis 35 3.36 Polyarteritis nodosa (PAN) 95 8.83 Cutaneous PAN 13 1.22 Wegener’s granulomatosis 147 13.83 Microscopic polyangiitis 42 3.94 Churg Straus syndrome 19 1.78 Henoch Schonlein purpura 232 21.80 Small vessel vasculitis 61 5.73 Behcet’s disease 145 13.62 Kawasaki disease 05 0.46 Undiagnosed 50 4.69 Others** 6 0.56
  • 9. CLINICAL MANIFESTATIONS • The Vasculitides are truly a ‘multisystem’ diseases. No organ or system is spared. • General Symptomatology : Fever Weight loss Malaise Fatigue Night sweats Anemia Generalised aches and pain
  • 10. CLINICAL MANIFESTATIONS : A GUIDE TO THE TYPE OF VESSELS INVOLVED CLINICAL MANIFESTATIONS: LARGE VESSELS MEDIUM VESSELS SMALL VESSELS Limb claudication Red and blue Panniculitis Purpura Asymmetric blood pressure Ulcer Vesicobullous lesions Absence of pulses Livedo reticularis. Urticaria Bruits Digital gangrene Glomerulonephritis Aortic dilatation Mononeuritis multiplex Alveolar haemorrhage Renovascular Hypertension Microaneurysm Splinter haemorrhage Reno-vascular hypertension Uveitis,episcleritis,scleritis Mucosal ulcer in bowel
  • 11. Continue… • SKIN: Skin commonly involved. o Palpable purpura is commonest dermal lesion. o Other specific lesions are:  nodules and plaques which may ulcerate  Infarcts  Ulcers  Pyoderma gangrenosum  Wide spread skin necrosis and gangrene.  Macules, papules,vesicles, blisters, and small bullae has been described.
  • 13. Muscles and Joints:  Features are common, but nonspecific. Arthralgia and Arthritis Generalised Myalgia and Weakness Claudication, Pain Eye ,Ear ,Nose and Throat: Scleritis Scleromalacia Perforation of globe Uveatis Recurrent Otitis media Hearing loss Recurrent sinusitis, nasal septum damage Several and recurrent oral ulcerations
  • 14. Airways and Lungs: Stridor Ventilatory compromise Cough Chest pain Expectoration and Hemoptysis Pulmonary lesions like: infiltrate nodules cavities mass lesions abscess
  • 15.
  • 16. Gastrointestinal tract:  most important G.I. manifestations are due to bowel ischemia. Kidneys:  Great diversity of lesions: Renovascular hypertension Infarction and Hematoma of kidneys Mild GNs to rapidly progressive GNs
  • 17. Nervous system: Peripheral Neuropathy, Stroke Reproductive system: Testicular Infarction Scrotal ulcers Penile ulcers on Glans and Shaft Cardiovascular system : Pericarditis, Myocardial infarction Aneurysmal rupture
  • 18. Approach to the patient • Diagnosis of vasculitis is considered in an any patient with unexplained illness. • Certain clinical abnormalities when present alone or in combination suggest a diagnosis of vasculitis like… 1.Palpable purpura 2.Pulmanary infiltrates 3. Microscopic hematuria 4.Chronic inflammatory sinusitis 5.Unexplained ischemic events 6.Glomerulonephritis with evidence of multisystem disease
  • 19.
  • 20. Laboratory Work-up • First to exclude the diseases which can mimic vasculitis. • To establish the category of vasculitis syndrome.  Hemogram : Normocytic Normochromic anemia Leukocytosis(>10% Eosinophils in CSS) Acute phase reactants: Raised ESR, CRP, alpha-2 globulin, fibrinogen, Thrombocytosis, ALP
  • 21. Continue…. Urine analysis: Hematuria Proteinuria Serum proteins: Hypergammaglobulinemia (mostly IgG type, IgA in HSP, WG) Complements levels usually decreased Antineutrophil cytoplasmic autoantibodies (ANCA): c-ANCA p-ANCA A or x-ANCA
  • 22. Continue…. Organ biopsy: Gold standard for diagnosis of vasculitis. Angiography : Especially for medium and large vessels.  Others: X-rays, CT Scan, MRI of thorax MRA USG Studies
  • 23. Basic principals of treatment • Glucocorticoids • Glucocorticoids + cytototoxic drugs • Antiviral therapy if indicated • Plasma exchange and IV Ig + or aspirin • Surgical correction and Angioplasty
  • 24. Continue… • Sympotomatic mangement in cases of hypersensitivity vasculitis • White blood cell counts every 1-2wks and WBC count should be maintained above > 3000/microL. • TMP-SMX should be given to every patient receiving glucocorticoids and cytotoxic drugs combination therapy.
  • 25. SMALL AND MEDIUM SIZED VASCULITIS SYNDROMES
  • 26. WEGENNER’S CHURG SRAUSS MICROSCOPIC GRANULOMATOS SYNDROME POLYANGITIS IS PAN 1.2:1 OVER ALL OVER ALL 1:1 NO MUCH DIFF. UNKNOWN UNKNOWN M:F FROM WESTRN 1:14(INDIA) DATA 4.5:1(INDIA) TYPE OF VESSELS SMALL ARTERIES SMALL AND SMALL VESSELS SMALL AND INVOLVED AND VEINS MEDIUM SIZED (ARTERIES, MEDIUM SIZED VESSELS CAPILLARIES, ARTERIES ONLY VENULES) SPECIFIC TRIAD: UPPER EXTRA PULMONARY PULMONARY FEATURE AND LOWER AIR VASCULAR CAPILLARIES ARTERY NOT WAYS WITH GRANULOMA INVOLVED, INVOLVED, KIDNEY LESIONS GNs +NT ANEURYSMS LABORATORY C-ANCA(>90%) p-ANCA (>48%) p-ANCA (75%) HEP B FINDINGS FALSE +VE ANTIGENEMIA, REPORTED HAIRY CELL LEUKEMIA
  • 28.  TAKAYASU’S ATERITIS  GIANT CEL ATERITIS (NON-SPECIFIC AORTO-ARTERITIS) (TEMPORAL ARTERITIS)  SPECIFIC FEMALE SEX MORE COMMON IN FEMALE PREDILICTIONS MORE COMMON IN WESTERN MORE COMMON IN ASIA COUNTRIES M:F- 1:1.6 (INDIA) RARE IN INDIA 1:9 (JAPAN) AGE: 15-25 YEARS AGE: MORE THAN 50 YEARS C/F: GENERAL SYMPTOMS WITH VASCULAR SYMPTOMS  HYPERTENSION IS MOST COMMON ASSOCIATED WITH POLYMYALGIA PRESENTATION. RHEUMATICA. DISEAESE CLASSIFY ON THE BASIS OF SITE OF INVOLVEMENT OF AORTA AND DISEASE INVOLVES ITS BRNCHES. CHARECTERISTICALLY ONE OR MORE BRANCHES OF CAROTID ARTERY. MIXED INVOLVEMENT IS THE
  • 30.
  • 31. SUMMARY • PATIENT SUSPECTED FOR PRIMARY VASCULITIS. • RULE OUT THE CAUSES WHICH CAN MIMIC VASCULITIS. • LOOK FOR DEMOGRAPHIC CHARACTERISTICS LIKE AGE,SEX, ETHINICITY,SMOKING STATUS. • DETERMINE THE SIZE OF VESSELS INVOLVED AND CATEGORIES THE TYPE OF VASCULITIS. • EXTENT OF ORGAN DAMGE TO BE ASSESSED. • SPECIFIC LABORATORIES WORK UP REQUIRED FOR CONFIRMATION OF DIAGNOSIS. • DECIDE THE APPOPRIATE TREATMENT